Pharmacokinetic Studies in Developmental Toxicology: Practical Considerations and Approaches

References

• Bass R, Ulbrich B, Hildebrandt A G, et al. Draft guideline on detection of toxicity to reproduction for medicinal products. Adverse Drug React Toxicol Rev 1991; 9: 127–141
   Google Scholar
• Environmental Protection Agency. Guidelines for developmental toxicity in risk assessment. Fed Register 1991; 56: 63798–826
   Google Scholar
• Nau H. Species differences in pharmacokinetics and drug teratogenesis. Environ Health Perspect 1986; 70: 113–29
   PubMed Web of Science ®Google Scholar
• Hauck R-S, Elmazar M MA, Plum C, Nau H. The enantioselective teratogenicity of 2-n-propyl-4-pentynoic acid (4-yn-VPA) is due to stereoselective intrinsic activity and not differences in pharmacokinetics. Toxicol Lett 1992; 60: 145–53
   PubMedGoogle Scholar
• Rowland M, Tozer T N. Clinical pharmacokinetics: concepts and applications. Lea and Febiger, Philadelphia 1980
   Google Scholar
• Gibaldi M, Perrier D. Pharmacokinetics, 2nd ed. Marcel Dekker, New York 1982
   Google Scholar
• Renwick A G. Pharmacokinetics in toxicology. Principles and methods of toxicology, 2nd ed., A W Hayes. Raven Press, New York 1989; 835–78
   Google Scholar
• Krauer B, Krauer F, Hytten F E. Drug disposition and pharmacokinetics in the maternal-placental-fetal unit. Pharmacol Ther 1980; 10: 301–28
   PubMed Web of Science ®Google Scholar
• Mattison D R, Blann E, Malek A. Physiological alterations during pregnancy: impact on toxicokinetics. Fundam Appl Toxicol 1991; 16: 215–8
   PubMedGoogle Scholar
• Nau H, Scott W J. Weak acids as teratogens: drug accumulation in the basic milieu of the early mammalian embryo. Nature 1986; 323: 276–8
   PubMedGoogle Scholar
• Waddell W J, Marlowe C. Transfer of drugs across the placenta. Pharmacol Ther 1981; 14: 375–90
   PubMedGoogle Scholar
• Clarke D O, Mebus C A, Miller F J, Welsch F. Protection against 2-methoxyethanol-induced terato-genesis by serine enantiomers: studies of potential alteration of 2-methoxyethanol pharmacokinetics. Toxicol Appl Pharmacol 1991; 110: 514–26
   PubMed Web of Science ®Google Scholar
• Price C J, George J D, Sadler B M, Marr M C, Kimmel C A, Schwetz B A, Morrissey R E. Teratologic evaluation of corn oil or distilled water in CD-I mice and CD rats. Toxicologist 1989; 9: 269
   Google Scholar
• Hen wood S M, Nokelby J A, Miller J M, Lane C P, Palazzolo M J. Time-mated rabbit teratology study. Toxicologist 1992; 12: 104
   Google Scholar
• Food and Drug Research Laboratories. Teratologic evaluation of FDA 73–69, sodium carboxymethyl-cellulose, in mice and rats. PB-245 526/9. NTIS, Arlington 1975
   Google Scholar
• Sullivan F M, McElhatton P R. A comparison of the teratogenic activity of the antiepileptic drugs carbamazepine, clonazepam, ethosuximide, phenobarbital, phenytoin, and primidone in mice. Toxicol Appl Pharmacol 1977; 40: 365–78
   PubMed Web of Science ®Google Scholar
• Office of the Federal Register National Archives and Records Administration. US Code of Federal Regulations. Title 21—Food and Drugs. US Government Printing Office, Washington, DC 1992, Part 184.1330
   Google Scholar
• Collins T FX, Welsh J J, Black T N, Graham S L, Brown L H. Study of the teratogenic potential of gum arabic. Food Chem Toxicol 1987; 25: 815–21
   PubMedGoogle Scholar
• Waynforth H B. Experimental and surgical technique in the rat. Academic Press, New York 1980
   Google Scholar
• Kimmel C A, Francis E Z. Proceedings of the workshop on the acceptability and interpretation of dermal developmental toxicity studies. Fundam Appl Toxicol 1990; 14: 386–98
   PubMedGoogle Scholar
• Wester R C, Maibach H I. In vivo percutaneous absorption. Dermatotoxicology, 3rd ed., F N Marzulli, H I Maibach. Hemisphere Publishing, Washington 1987; 135–52
   Google Scholar
• Gargas M L, Andersen M E. Determining kinetic constants of chlorinated ethane metabolism in the rat from rates of exhalation. Toxicol Appl Pharmacol 1989; 99: 344–53
   PubMed Web of Science ®Google Scholar
• Andersen M E, Gargas M L, Jones R A, Jenkins L J. The use of inhalation techniques to assess the kinetic constants of 1,1-dichloroethylene metabolism. Toxicol Appl Pharmacol 1979; 47: 395–409
   PubMed Web of Science ®Google Scholar
• Gargas M L, Andersen M E, Clewell H J, III. A physiologically-based simulation approach for determining metabolic constants from gas uptake data. Toxicol Appl Pharmacol 1986; 86: 341–52
   PubMed Web of Science ®Google Scholar
• Dring L G. Methods for studying metabolism and distribution in vivo of radiolabeled drugs. Biochemical toxicology: a practical approach, K Snell, B Mullock. IRL Press, Oxford 1987; 3–22
   Google Scholar
• Syllabus for the Laboratory Animal Technologist, G R Collins. American Association for Laboratory Animal Science, Joliet 1972; 440–5, publication 72–2, Appendix, Table 2
   Google Scholar
• Jacobs P, Adriaenssens L. A simple method for repeated blood sampling in small animals. J Lab Clin Med 1970; 75: 1013–6
   PubMedGoogle Scholar
• Upton R A. Simple and reliable method for serial sampling of blood from rats. J Pharm Sci 1975; 64: 112–4
   PubMed Web of Science ®Google Scholar
• Heim R A. A practical technique for obtaining multiple blood samples from rabbits. Lab Animal 1989; 18: 32–3
   Google Scholar
• Bazare J, Jr, Leamons M L, Young J F. Sampling methods for pharmacokinetic studies in the mouse. J Pharmacol Methods 1981; 5: 99–120
   PubMedGoogle Scholar
• Scott W J, Duggan C A, Schreiner C M, Collins M D. Reduction of embryonic intracellular pH: a potential mechanism of acetazolamide-induced limb malformations. Toxicol Appl Pharmacol 1990; 103: 238–54
   PubMed Web of Science ®Google Scholar
• Pelissier J-P, Yahia A, Chobert J-M, Ribadeau Dumas B. Isolation and characterization of the principle caseins in rat milk. J Dairy Res 1980; 47: 97–102
   Web of Science ®Google Scholar
• West R W. The exposure of fetal and suckling rats to saccharin from dosed maternal animals. Toxicol Lett 1979; 4: 127–33
   Web of Science ®Google Scholar
• McBurney J J, Meier H, Hoag W G. Device for milking mice. J Lab Clin Med 1964; 64: 485–7
   PubMedGoogle Scholar
• Woolley D E, Talens G M. Distribution of DDT, DDD, and DDE in tissues of neonatal rats and in milk and other tissues of mother rats chronically exposed to DDT. Toxicol Appl Pharmacol 1971; 18: 907–16
   PubMed Web of Science ®Google Scholar
• Hayes W J, Jr. Dosage relationships associated with DDT in milk. Toxicol Appl Pharmacol 1976; 38: 19–28
   PubMed Web of Science ®Google Scholar
• Fisher A N, Neale M G, Smith D A. Methods for the estimation of the excretion of proxicromil and its metabolites in the milk of nursing mothers. Xenobiotica 1981; 11: 871–7
   PubMed Web of Science ®Google Scholar
• Benard P, Cambon C, Declume C. Passage of radioactivity into the milk of rats treated with [14C]-carbaryl. Toxicol Lett 1979; 4: 149–53
   Web of Science ®Google Scholar
• Peng C-T. Sample preparation in liquid scintillation counting. Amersham International, Amersham 1977
   Google Scholar
• Ullberg S. The techniques of whole body autoradiography: cryosectioning of large specimens. Science Tools, The LKB Instrument Journal, Special Issue, O Alvfeldt. LKB-Producter AB, Sweden 1977; 2–29
   Google Scholar
• Geary W A, Wooten G F. Quantitative film autoradiography of opiate agonist and antagonist binding in rat brain. J Pharmacol Exp Ther 1983; 225: 234–40
   PubMed Web of Science ®Google Scholar
• Waddell W J. Localization and metabolism of drugs in the fetus. Fed Proc 1972; 31: 52–61
   PubMedGoogle Scholar
• Waddell W J, Marlowe G C. Disposition of drugs in the fetus. Perinatal pharmacology and therapeutics, B L Mirkin. Academic Press, New York 1976; 119–69
   Google Scholar
• Pohland R C, Byrd T K, Hamilton M, Koons J R. Placental transfer and fetal distribution of fluoxetine in the rat. Toxicol Appl Pharmacol 1989; 98: 198–205
   PubMed Web of Science ®Google Scholar
• Mebus C A, Clarke D O, Stedman D B, Welsch F. 2-Methoxyethanol metabolism in pregnant CD-I mice and embryos. Toxicol Appl Pharmacol 1992; 112: 87–94
   PubMedGoogle Scholar
• Olanoif L S, Anderson J M. Controlled-release of tetracycline-III: a physiological pharmacokinetic model of the pregnant rat. J Pharmacokinet Biopharm 1980; 8: 599–620
   PubMedGoogle Scholar
• Nau H, Zierer R, Spielmann H, Neubert D, Gansau Ch. A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrations. Life Sci 1981; 29: 2803–14
   PubMed Web of Science ®Google Scholar
• Nau H. Teratogenic valproic acid concentrations: infusion by implanted minipumps vs. conventional injection regimen in the mouse. Toxicol Appl Pharmacol 1985; 80: 243–50
   PubMed Web of Science ®Google Scholar
• Reiners J, Wittfoht W, Nau H, Vogel R, Tenschert B, Spielmann H. Teratogenesis and pharmacokinetics of cyclophosphamide after drug infusion as compared to injection in the mouse during day 10 of gestation. Pharmacokinetics in teratogenesis, vol. 2, experimental aspects in vivo and in vitro, H Nau, W J Scott, Jr. CRC Press, Boca Raton 1987; 41–8
   Google Scholar
• Clarke D O, Duignan J M, Welsch F. 2-Methoxyacetic acid dosimetry-teratogenicity relationships in 2-methoxyethanol exposed CD-I mice. Toxicol Appl Pharmacol 1992; 114: 77–87
   PubMed Web of Science ®Google Scholar
• Bowers W F, Fulton S P. Equilibrium nature of partition methods for free ligand assay. Amicon division application note. W. R. Grace & Co., Danvers, MA 1988, publication 480
   Google Scholar
• Wittfoht W, Duwe K, Kuhnz W, Nau H. Microscale ultrafiltration technique for determining free drug in 50-μ1 serum samples. Clin Chem 1984; 30: 878–9
   PubMedGoogle Scholar
• Flint O P, Brown L P. Metabolism of teratogens by mammalian embryos: an in vitro investigation. Pharmacokinetics in teratogenesis, vol. 2, experimental aspects in vivo and in vitro, H Nau, W J Scott, Jr. CRC Press, Boca Raton 1987; 133–43
   Google Scholar
• Kochhar D M, Kraft J, Nau H. Teratogenicity and disposition of various retinoids in vivo and in vitro. Pharmacokinetics in teratogenesis, vol. 2, experimental aspects in vivo and in vitro, H Nau, W J Scott, Jr. CRC Press, Boca Raton 1987; 173–86
   Google Scholar
• New D AT. Whole-embryo culture and the study of mammalian embryos during organogenesis. Biol Rev 1978; 53: 81
   PubMed Web of Science ®Google Scholar
• Freeman S J, Coakley M E, Brown N A. Post-implantation embryo culture for studies of teratogenesis. Biochemical toxicology. A practical approach, K Snell, B Mullock. IRL Press, Oxford 1987; 83–107
   Google Scholar
• Cockroft D L. Dissection and culture of postimplantation embryos. Postimplantation mammalian embryos, a practical approach, A J Copp, D L Cockroft. IRL Press, Oxford 1990; 15–40
   Google Scholar
• Juchau M R. Whole embryo culture: preinduction in vivo and metabolizing activity in vivo. Pharmacokinetics in teratogenesis, vol. 2, experimental aspects in vivo and in vitro, H Nau, W J Scott, Jr. CRC Press, Boca Raton 1987; 121–32
   Google Scholar
• Juchau M R, Lee Q P, Fantel A G. Xenobiotic biotransformation/activation in organogenesis-stage conceptal tissues: implications for embryotoxicity and teratogenesis. Drug Metab Rev 1992; 24: 195–238
   PubMed Web of Science ®Google Scholar
• Faustman-Watts E M, Namkung M J, Greenaway J C, Juchau M R. Analyses of metabolites of 2-acetyl-aminofluorene generated in an embryo culture system: relationship of biotransformation to teratogenicity in vitro. Biochem Pharmacol 1985; 34: 2953
   PubMed Web of Science ®Google Scholar
• Yonemoto J, Brown N A, Webb M. Effects of dimethoxyethyl phthalate, monomethoxyethyl phthalate, 2-methoxyethanol and methoxyacetic acid on post-implantation rat embryos in culture. Toxicol Lett 1984; 21: 97–102
   PubMed Web of Science ®Google Scholar
• Bechter R, Schön H. Use of the whole-embryo culture system in drug safety assessment. Toxic In Vitro 1988; 2: 195–203
   PubMedGoogle Scholar
• Rawlings S J, Shuker D EG, Webb M, Brown N A. The teratogenic potential of alkoxy acids in post-implantation rat embryo culture: structure-activity relationships. Toxicol Lett 1985; 28: 49–58
   PubMed Web of Science ®Google Scholar
• Greenaway J C, Fantel A G, Juchau M R. On the capacity of nitroheterocyclic compounds to elicit an unusual axial asymmetry in cultured rat embryos. Toxicol Appl Pharmacol 1986; 82: 307–15
   PubMed Web of Science ®Google Scholar
• Brown N A, Coakley M E, Clarke D O. Structure-teratogenicity relationships of valproic acid congeners in whole-embryo culture. Approaches to elucidate mechanisms in teratogenesis, F Welsch. Hemisphere Publishing, Washington 1987; 17–31
   Google Scholar
• Oglesby L A, Ebron-McCoy M T, Logsdon T R, Copeland F, Beyer P E, Kavlock R J. In vitro embryo-toxicity of a series of para-substituted phenols: structure, activity, and correlation with in vivo data. Teratology 1992; 45: 11–33
   PubMedGoogle Scholar
• Lewandowski C, Klug S, Nau H, Neubert D. Pharmacokinetic aspects of drug effects in vitro: effects of serum protein binding on concentration and teratogenicity of valproic acid and 2-en-valproic acid in whole embryos in culture. Arch Toxicol 1986; 58: 239–42
   PubMedGoogle Scholar
• Brown N A. Teratogenicity of carboxylic acids: distribution studies in whole embryo culture. Pharmacokinetics in teratogenesis, vol. 2, experimental aspects in vivo and in vitro, H Nau, W J Scott, Jr. CRC Press, Boca Raton 1987; 153–63
   Google Scholar
• Sadler T W, Shum L, Warner C W, Kate Smith M. The role of pharmacokinetics in determining the response of rodent embryos to teratogens in whole-embryo culture. Toxicol In Vitro 1988; 2: 175–80
   PubMedGoogle Scholar
• Hunter E S, Tugman J A, Sulik K K, Sadler T W. Pharmacokinetics of ethanol induced malformations in vitro. Toxicologist 1992; 12: 332
   Google Scholar
• Sadler T W, Horton W E, Jr, Hunter E S. Mammalian embryos in culture: a new approach to investigating normal and abnormal developmental mechanisms. Developmental mechanisms: normal and abnormal. Prog Clin Biol Res, J W Lash, L Saxen. Alan R. Liss, New York 1985; vol 171: 227–40
   Google Scholar
• Stark K L, Juchau M R. Microinjection of cultured rat embryos: a new technique for studies in chemical dysmorphogenesis. Toxicol Appl Pharmacol 1989; 100: 414–6
   Google Scholar
• Stark K L, Lee Q P, Mankung M J, Harris C, Juchau M R. Dysmorphogenesis elicited by microinjected acetaminophen analogs and metabolites in rat embryos cultured in vitro. J Pharmacol Exp Ther 1990; 255: 74–82
   PubMed Web of Science ®Google Scholar
• Lee Q P, Juchau M R, Creech Kraft J. Microinjection of cultured rat embryos: studies with retinol, 13-cis- and all-trans-retinoic acid. Teratology 1991; 44: 313–23
   PubMedGoogle Scholar
• Shepard T H, Fantel A G, Mirkes P E, et al. Teratology testing. I. Development and status of short-term prescreens. II. Biotransformation of teratogens as studied in whole embryo culture. Developmental pharmacology, S M Mac-Loed, A B Okey, S P Spielberg. Raven Press, New York 1983; 147–64
   Google Scholar
• Kitchen K T, Schmid B P, Sanyal M K. Teratogenicity of cyclophosphamide in a coupled microsomal activating/embryo culture system. Biochem Pharmacol 1981; 30: 59–64
   PubMedGoogle Scholar
• Mirkes P E, Fantel A G. Maternal influences on development. Postimplantation mammalian embryos, a practical approach, A J Copp, D L Cockroft. IRL Press, Oxford 1990; 235–48
   Google Scholar
• Bechter R, Bouis P, Fischer V. Primary hepatocyte culture as an activating system for xenobiotica tested in the rat whole embryo culture in vitro. Alternative methods in toxicology, A M Goldberg. Mary Ann Liebert, New York 1989; vol 7: 313–26
   Google Scholar
• Oglesby L A, Ebron M T, Beyer P E, Carver B D, Kavlock R J. Co-culture of rat embryos and hepatocytes: in vitro detection of a proteratogen. Teratogenesis Carcinog Mutagen 1986; 6: 129–38
   PubMedGoogle Scholar
• Himmelstein K J, Lutz R J. A review of the applications of physiologically based pharmacokinetic modeling. J Pharmacokinet Biopharm 1979; 7: 127–45
   PubMedGoogle Scholar
• Andersen M E. Physiological modelling of organic compounds. Ann Occup Hyg 1991; 35: 309–21
   PubMed Web of Science ®Google Scholar
• Krishnan K, Andersen M E. The role of physiological modeling in reducing animal use in toxicology research. Alternative methods in toxicology, A M Goldberg. Mary Ann Liebert, New York 1991; vol 8: 113–33
   Google Scholar
• Conolly R B, Andersen M E. Biologically based pharmacodynamic models: tools for toxicological research and risk assessment. Annu Rev Pharmacol Toxicol 1991; 31: 503–23
   PubMed Web of Science ®Google Scholar
• Gabrielsson J L, Paazlow L K. A physiological pharmacokinetic model for morphine disposition in the pregnant rat. J Pharmacokinet Biopharm 1983; 11: 147–63
   PubMedGoogle Scholar
• Gabrielsson J L, Paalzow L K, Nordstrom L. A physiologically based pharmacokinetic model for theophylline disposition in the pregnant and nonpregnant rat. J Pharmacokinet Biopharm 1984; 12: 149–65
   PubMedGoogle Scholar
• Gabrielsson J L, Johansson P, Bondesson U, Paalzow L K. Analysis of methadone disposition in the pregnant rat by means of a physiological flow model. J Pharmacokinet Biopharm 1985; 13: 355–72
   PubMedGoogle Scholar
• Gabrielsson J L, Johansson P, Bondesson U, Karlsson M, Paalzow L K. Analysis of pethidine disposition in the pregnant rat by means of a physiological flow model. J Pharmacokinet Biopharm 1986; 14: 381–95
   PubMedGoogle Scholar
• Fisher J W, Whittaker T A, Taylor D H, Clewell H J, III, Andersen M E. Physiologically-based pharmacokinetic modeling of the pregnant rat: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. Toxicol Appl Pharmacol 1989; 99: 395–414
   PubMed Web of Science ®Google Scholar
• Fisher J W, Whittaker T A, Taylor D H, Clewell H J, III, Andersen M E. Physiologically based pharmacokinetic modeling of the lactating rat and nursing pup: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. Toxicol Appl Pharmacol 1990; 102: 497–513
   PubMed Web of Science ®Google Scholar
• O'Flaherty E J, Scott W, Schreiner C, Beliles R P. A physiologically based kinetic model of rat and mouse gestation: disposition of a weak acid. Toxicol Appl Pharmacol 1992; 112: 245–56
   PubMed Web of Science ®Google Scholar
• Clarke D O, Willett K L, Elswick B A, Conolly R B, Welsch F. Scale-up of a physiologically-based pharmacokinetic model for 2-methoxyethanol and 2-methoxyacetic acid from pregnant mice to rats. Toxicologist 1992; 12: 101
   Google Scholar
• O'Flaherty E J, Andriot M D. Predicting blood lead during human pregnancy. Toxicologist 1992; 12: 212
   Google Scholar
• Rogers J M, Setzer R W, Shuey D L, et al. Development of biologically-based dose response models: 5-fluorouracil dose response based on fetal outcome and linkage to mechanistic endpoints. Teratology 1992; 45: 457
   Google Scholar
• Clarke D O, Elswick B A, Welsch F, Conolly R B. Pharmacokinetics of 2-methoxyethanol and 2-methoxyacetic acid in the pregnant mouse: a physiologically-based mathematical model. Toxicol Appl Pharmacol 1993; 121: 239–252
   PubMed Web of Science ®Google Scholar
• Gallo J M, Lam F C, Perrier D G. Area method for the estimation of partition coefficients for physiological pharmacokinetics models. J Pharmacokinet Biopharm 1987; 15: 271–80
   PubMedGoogle Scholar
• Dallas C E, Gallo J M, Chen X M, Muralidhara S, O'Barr K, Bruckner J V. Physiologically-based model parameter estimation from perchloroethylene tissue pharmacokinetics. Toxicologist 1991; 11: 33
   Google Scholar
• Sato A, Nakajima T. Partition coefficients of some aromatic hydrocarbons and ketones in water, blood and oil. Br J Ind Med 1979; 36: 231–4
   PubMedGoogle Scholar
• Gargas M L, Burgess R J, Voisard D E, Cason G H, Andersen M E. Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. Toxicol Appl Pharmacol 1989; 98: 87–99
   PubMed Web of Science ®Google Scholar
• Crank W D. Partition coefficients of volatile organic compounds determined by liquid scintillation counting. Toxicologist 1992; 12: 262
   Google Scholar
• Jepson G W. A kinetic model for acetylcholinesterase inhibition by diisopropylfluorophosphate in crude rat brain homogenate. Wright State University, Dayton 1986, M.Sc. Thesis
   Google Scholar
• Jepson G W, Hoover K, Black R K, McCafferty J D, Mahle D A, Gearhart J M. Partition coefficient determination for non-volatile and intermediate volatility chemicals in biological tissues. Toxicologist 1992; 12: 996
   Google Scholar
• Gargas M L, Andersen M E. Determining kinetic constants of chlorinated ethane metabolism in the rat from rates of exhalation. Toxicol Appl Pharmacol 1989; 99: 344–53
   PubMed Web of Science ®Google Scholar
• Gargas M L. Chemical-specific constants for physiologically-based pharmacokinetic models. CIIT Activities 1991; 11: 1–9
   Google Scholar
• Csanady G A, Guengerich F P, Bond J A. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice. Carcinogenesis 1992; 13: 1143–53
   PubMed Web of Science ®Google Scholar
• The mechanics of sorbent extraction. Sorbent extraction technology handbook, K C Van Home. Analytichem International, California 1990; 18–23
   Google Scholar
• Folch J, Lees M, Sloane Stanley G H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957; 226: 497–509
   PubMed Web of Science ®Google Scholar
• Estibeiro J P, Copp A J, Cockroft D L, Brown N A, Clarke D O. Extraction of macromolecules from embryonic material. Postimplanlation mammalian embryos. A practical approach, A J Copp, D L Cockroft. Oxford University Press, Oxford 1990; 173–204
   Google Scholar
• Bazare J J, Jr, Nelson C J, Young J F. Pharmacokinetics of 2,4,5-T in mice as a function of dose and gestational status. Reprod Toxicol 1990; 4: 137–44
   PubMedGoogle Scholar
• Creech Kraft J, Kochar D M, Scott W J, Nau H. Low teratogenicity of 13-cis-retinoic acid (isotretinoin) in the mouse corresponds to low embryo concentrations during organogenesis: comparison to the all-trans isomer. Toxicol Appl Pharmacol 1987; 87: 474–82
   PubMed Web of Science ®Google Scholar
• Eckhoff C, Bailey J R, Collins M D, Slikker W, Jr, Nau H. Influence of dose and pharmaceutical formulation of vitamin A on plasma levels of retinyl esters and retinol and metabolic generation of retinoic acid compounds and B-glucuronides in the cynomolgus monkey. Toxicol Appl Pharmacol 1991; 111: 116–27
   PubMedGoogle Scholar
• Sangalli L, Bortolotti A, Passerini F, Bonati M. Placental transfer, tissue distribution, and pharmacokinetics of cyclosporine in the pregnant rabbit. Drug Metab Dispos 1990; 18: 102–6
   PubMedGoogle Scholar
• Hendrie T A, Rowland J R., Binkerd P E, Hendrickx A G. Developmental toxicity and pharmacokinetics of phenytoin in the rhesus macaque: an interspecies comparison. Reprod Toxicol 1990; 4: 257–66
   PubMedGoogle Scholar
• Nau H, Wittfoht W. Valproic acid and several metabolites: quantitative determination in serum, urine, breast milk and tissues by gas-chromatography-mass spectrometry using selected ion monitoring. J Chromatogr 1981; 226: 69–78
   PubMed Web of Science ®Google Scholar
• Wittfoht W, Scott W J, Nau H. Assay of methoxyacetic acid in body fluids and tissues by gas chromatography-mass spectrometry following tert.-butyldimethylsilylation. J Chromatogr 1988; 448: 433–8
   PubMedGoogle Scholar
• Eckhoff C, Wittfoht W, Slikker W, Nau H. Characterization of oxidized and glucuronidated metabolites of retinol in monkey plasma by thermospray liquid chromatography/mass spectrometry. Biomed Environ Mass Spectrom 1990; 19: 428–33
   PubMedGoogle Scholar
• Nicholson J K, Wilson I H. High resolution nuclear magnetic resonance spectroscopy of biological samples as an aid to drug development. Prog Drug Res 1987; 31: 427–79
   PubMedGoogle Scholar
• Nicholson J K, Wilson I H. High resolution proton magnetic resonance spectroscopy of biological fluids. Prog Nucl Magn Reson Spectrosc 1989; 21: 449–501
   Web of Science ®Google Scholar
• Sumner S CJ, Stedman D B, Clarke D O, Welsch F, Fennell T R. Characterization of urinary metabolites from [1,2, methoxy-13C]-2-methoxyethanol in mice using 13C nuclear magnetic resonance spectroscopy. Chem Res Toxicol 1992; 5: 553–60
   PubMed Web of Science ®Google Scholar
• Lehman E L. Theory of point estimation. Wiley, New York 1983
   Google Scholar
• Sabourin P J, Bechtold W E, Griffith W C, Birnbaum L S, Lucier G, Henderson R F. Effect of exposure concentration, exposure rate, and route of administration on metabolism of benzene by F344 rats and B6C3F1 mice. Toxicol Appl Pharmacol 1989; 99: 421–44
   PubMed Web of Science ®Google Scholar
• Draper N R, Smith H. Fitting a straight line by least squares. Applied regression analysis. 2nd edition. Wiley and Sons. 1981; 1–69
   Google Scholar